IBO IMPACT BIOMEDICAL INC.
Healthcare · Pharmaceutical Preparations · Market cap: $554.2M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $155.6K | $0 |
| 2024-Q4 | $5.2K | $17.1K |
| 2025-Q1 | $310 | $1.2M |
| 2025-Q2 | $0 | $4.6M |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $57.8K |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $1.7K |
| 2026-Q4 | $0 | $0 |
Bought$161.0K7 buy days
Sold$5.9M21 sell days
Net insider flow-$5.7Mnet selling · 5 years
Latest trade2026-09-24DSS, INC.
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-09-24 | Sell | DSS, INC. | 10% owner | 156 | $7.06 | $1.1K | 1 |
| 2026-09-23 | Sell | DSS, INC. | 10% owner | 27 | $6.95 | $188 | 1 |
| 2026-09-22 | Sell | DSS, INC. | 10% owner | 723 | $0.55 | $398 | 1 |
| 2026-03-27 | Sell | Macko Todd D | CFO | 43,400 | $0.56 | $24.3K | 1 |
| 2026-03-25 | Sell | Macko Todd D | CFO | 1,600 | $0.60 | $960 | 1 |
| 2026-03-23 | Sell | Grady Jason | Director | 50,000 | $0.65 | $32.5K | 1 |
| 2025-05-27 | Sell | DSS, INC. | 10% owner | 45,400 | $0.54 | $24.5K | 1 |
| 2025-05-22 | Sell | DSS, INC. | 10% owner | 115,600 | $0.55 | $63.6K | 1 |
| 2025-04-04 | Sell | DSS, INC. | 10% owner | 890,800 | $0.95 | $846.3K | 1 |
| 2025-04-04 | Sell | Chan Heng Fai Ambrose | Director | 180,000 | $0.96 | $172.8K | 1 |
| 2025-04-03 | Sell | Chan Heng Fai Ambrose | Director | 703,186 | $0.54 | $379.7K | 2 |
| 2025-04-02 | Sell | Chan Heng Fai Ambrose | Director | 884,776 | $0.60 | $531.4K | 4 |
| 2025-04-01 | Sell | Chan Heng Fai Ambrose | Director | 2,226,918 | $1.17 | $2.6M | 3 |
| 2025-03-31 | Sell | Chan Heng Fai Ambrose | Director | 300,000 | $1.03 | $309.0K | 1 |
| 2025-03-27 | Sell | DSS, INC. | 10% owner | 47,681 | $2.50 | $119.2K | 1 |
| 2025-03-26 | Sell | DSS, INC. | 10% owner | 58,139 | $3.13 | $182.2K | 2 |
| 2025-03-21 | Sell | DSS, INC. | 10% owner | 166,600 | $3.30 | $549.8K | 1 |
| 2025-03-20 | Buy | DSS, INC. | 10% owner | 200 | $1.55 | $310 | 1 |
| 2024-12-05 | Buy | Heuszel Frank D | CEO | 500 | $2.26 | $1.1K | 1 |
| 2024-12-02 | Sell | DSS, INC. | 10% owner | 20 | $2.90 | $58 | 1 |
| 2024-11-27 | Buy | Heuszel Frank D | CEO | 500 | $2.61 | $1.3K | 1 |
| 2024-11-26 | Buy | Heuszel Frank D | CEO | 1,050 | $2.61 | $2.7K | 2 |
| 2024-11-18 | Sell | DSS, INC. | 10% owner | 5,000 | $3.02 | $15.1K | 1 |
| 2024-11-13 | Sell | DSS, INC. | 10% owner | 200 | $2.80 | $560 | 1 |
| 2024-11-12 | Sell | DSS, INC. | 10% owner | 500 | $2.76 | $1.4K | 1 |
| 2024-09-18 | Buy | DSS, INC. | 10% owner | 1,000 | $2.33 | $2.3K | 1 |
| 2024-09-17 | Buy | DSS, INC. | 10% owner | 7,800 | $2.40 | $18.7K | 1 |
| 2024-09-16 | Buy | DSS, INC. | 10% owner | 50,000 | $2.69 | $134.5K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Chan Heng Fai Ambrose | Director | $0 | $4.0M | 2025-04-04 |
| DSS, INC. | 10% owner | $155.9K | $1.8M | 2026-09-24 |
| Grady Jason | Director | $0 | $32.5K | 2026-03-23 |
| Macko Todd D | CFO | $0 | $25.3K | 2026-03-27 |
| Heuszel Frank D | CEO | $5.2K | $0 | 2024-12-05 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.